IMAI Hisao

イマイヒサオ | IMAI Hisao

Affiliation and department：
Job title： Associate Professor
Papers (29)：

Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, Hitoshi Kawazoe, Kazuki Tanaka, Yukiyoshi Fujita, Masakazu Abe, Hisao Imai, Masato Karayama, Yoh Hayasaki, et al. Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis. BMC cancer. 2022. 22. 1. 310-310
Hisao Imai, Daijiro Kobayashi, Kyoichi Kaira, Sayaka Kawashima, Ken Masubuchi, Masumi Murata, Takeshi Ebara, Yoshizumi Kitamoto, Koichi Minato. Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy. Radiology and Oncology. 2022. 56. 2. 228-237
Kosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Atsuto Mouri, Yu Miura, Kunihiko Kobayashi, Hisao Imai, Yohji Matsusaka, Ichiei Kuji, et al. Visual Assessment of 18F-FDG Uptake on PET to Predict Survival Benefit to PD-1 Blockade in Non-Small Cell Lung Cancer. Clinical Nuclear Medicine. 2022. 47. 2. 108-116
Tomoyasu Mimori, Takehito Shukuya, Ryo Ko, Yusuke Okuma, Tomonobu Koizumi, Hisao Imai, Yuichi Takiguchi, Eisaku Miyauchi, Hiroshi Kagamu, Tomohide Sugiyama 10, et al. Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study. Cancers. 2022. 14. 2. 331
Hisao Imai, Kyoichi Kaira, Ken Masubuchi, Koichi Minato. Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study. Current Oncology. 2021. 29. 1. 163-172

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page